NEWS
NORMAN, OKLA. – The University of Oklahoma announced today the students named to its spring 2025 honor roll, a distinction given to those who achieve the highest academic standards.
A total of 10,801 students were named to the spring 2025 honor roll. Of these students, 4,564 were named to the President’s Honor Roll for earning an “A” grade in all their courses.
The honor roll recognizes undergraduate students at OU’s Norman campus and OU Health Sciences. Most colleges include full-time students who completed at least 12 letter-graded credit hours. Those with a 4.0 grade-point average were named to the President’s Honor Roll. Students with a grade-point average of 3.5 or higher are named to the Dean’s Honor Roll. In the Gallogly College of Engineering and the Mewbourne College of Earth and Energy, students with a grade-point average of 3.0 or higher qualify for recognition.
A searchable honor roll list for spring 2025 is available for download online. Students who are on both the President’s Honor Roll and Dean’s Honor Roll are denoted by an asterisk.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. For more information about the university, visit www.ou.edu.
Robin Zape-tah-hol-ah Starr Minthorn (Kiowa), professor and chair of the Department of Educational Leadership and Policy Studies in the University of Oklahoma Jeannine Rainbolt College of Education, has been elected president of the Association for the Study of Higher Education (ASHE) — becoming the first Indigenous person to hold this role in the organization’s history.
A new study from the University of Oklahoma suggests that small genetic differences in two proteins – previously known for their role in premature infants’ lungs – may also influence how their eyes develop, potentially affecting the risk of retinopathy of prematurity (ROP).
University of Oklahoma researcher Elizabeth Wellberg, Ph.D., is the senior author of a review article in The Journal of Clinical Investigation that gathers current research evidence about the effects of GLP-1 drugs, like Ozempic and Zepbound, on cancer risk.
